Porcine interferon-like recombinant protein and use thereof
AssigneeBodn Biotech Inc.
InventorsChunsheng Mao, Shaoyu Li, Jianyu Fang, Bin Xu, Jizhi Li, Jingchuang Chen, Yale Mao
Life of this patent
Estimating the term…
Loading patent…
AssigneeBodn Biotech Inc.
InventorsChunsheng Mao, Shaoyu Li, Jianyu Fang, Bin Xu, Jizhi Li, Jingchuang Chen, Yale Mao
Estimating the term…
This invention relates to the field of biomedicine and specifically to a porcine interferon-like recombinant protein and its applications. By constructing and screening a PoIFN-α DNA shuffling bacterial library, a highly active recombinant protein Porferon was obtained. Porferon exhibits potent anti-infective activity against a broad range of porcine pathogens, including viruses, bacteria, and parasites. Its biological activity is significantly superior to that of natural porcine interferon. As such, Porferon can be used in the development of therapeutics for the prevention or treatment of infectious diseases in pigs, offering a novel and effective solution for clinical applications in veterinary medicine.
A porcine interferon-like recombinant protein, selected from one of the following:
Dependencies are inferred from the claim text.